↓ Skip to main content
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Readers on

mendeley
245 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial
Published in
Journal of Clinical Oncology, June 2018
DOI 10.1200/jco.2018.78.5865
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 36 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 245 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 245 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 34 14%
Other 33 13%
Student > Ph. D. Student 21 9%
Student > Master 13 5%
Student > Doctoral Student 12 5%
Other 41 17%
Unknown 91 37%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 92 38%
Nursing and Health Professions 9 4%
Biochemistry, Genetics and Molecular Biology 8 3%
Chemistry 8 3%
Pharmacology, Toxicology and Pharmaceutical Science 7 3%
Other 21 9%
Unknown 100 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 89. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2025.
All research outputs
#588,651
of 33,087,078 outputs
Outputs from Journal of Clinical Oncology
#1,260
of 30,598 outputs
Outputs of similar age
#9,955
of 364,590 outputs
Outputs of similar age from Journal of Clinical Oncology
#24
of 687 outputs
Altmetric has tracked 33,087,078 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 30,598 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.6. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,590 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 687 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.